Mechanisms of spontaneous and glucocorticoid (GC)-induced lymphocyte apoptosis in atopic bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 266s Year: 2001
T cell resistance to Fas-mediated apoptosis during atopic bronchial asthma (ABA) Source: Eur Respir J 2002; 20: Suppl. 38, 29s Year: 2002
The abnormalities in spontaneous and Fas-induced apoptosis in atopic bronchial asthma (ABA): the key to chronic lung inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 228s Year: 2006
Lymphocyte apoptosis in atopic bronchial asthma: the mechanisms, role in pathogenesis and therapy Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004
The influence of topical glucocorticoid on apoptosis of lymphocytes during allergic rhinitis Source: Annual Congress 2008 - Asthma: mechanisms and treatment Year: 2008
Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism. Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
Chemokine expression, apoptosis, and proliferation in the airway mucosa at steroid-mediated resolution of allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 32s Year: 2003
Thymic stromal lymphopoietin (TSLP) as a local biomarker of hypertrophic changes in the synonasal mucosa in children with atopic bronchial asthma (BA) and allergic rhinitis (AR) Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
Changes in lung functions and inflammatory markers in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005
Spontaneous, Fas- and glucocorticoid (GC)-mediated lymphocyte apoptosis in atopic bronchial asthma(ABA): mechanisms, role in pathogenesis and therapy Source: Eur Respir J 2003; 22: Suppl. 45, 290s Year: 2003
The development of an airway hyperresponsiveness (AHR) depends on mast cells following sensitization without adjuvant Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis Year: 2006
Local application of FTY720 to the lung abrogates experimental asthma by altering myeloid dendritic cell function Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006
IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? Source: International Congress 2017 – Monitoring asthma control Year: 2017
Humoral markers of inflammation in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2004; 24: Suppl. 48, 595s Year: 2004
Caspase-3 activity of lymphocytes in bronchial asthma Source: Annual Congress 2006 - Cellular mechanisms of airway disease Year: 2006
T-cell co-stimulatory molecules: their role in allergic immune reactions Source: Eur Respir J 2007; 29: 1246-1255 Year: 2007
Relationship between allergen-induced increase of AHR to bradykinin, expression of the proliferation marker Ki-67 and eosinophils in bronchial mucosa of atopic asthmatics Source: Annual Congress 2003 - Modulation of bronchial hyperreactivity and immune response in the airways Year: 2003
Master switches of T-cell activation and differentiation Source: Eur Respir J 2007; 29: 804-812 Year: 2007
In situ proliferation of bronchial T-cells in asthmaSource: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009
Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018